| __timestamp | Dr. Reddy's Laboratories Limited | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 60987000 |
| Thursday, January 1, 2015 | 62786000000 | 125542000 |
| Friday, January 1, 2016 | 62427000000 | 210460000 |
| Sunday, January 1, 2017 | 62453000000 | 275119000 |
| Monday, January 1, 2018 | 65724000000 | 409539000 |
| Tuesday, January 1, 2019 | 70421000000 | 547758000 |
| Wednesday, January 1, 2020 | 80591000000 | 736300000 |
| Friday, January 1, 2021 | 86645000000 | 904200000 |
| Saturday, January 1, 2022 | 100551000000 | 1080300000 |
| Sunday, January 1, 2023 | 42907000000 | 1262200000 |
| Monday, January 1, 2024 | 115557000000 | 1530500000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, cost management is crucial for maintaining competitive advantage. This analysis compares the cost of revenue for Vertex Pharmaceuticals Incorporated and Dr. Reddy's Laboratories Limited from 2014 to 2023. Over this period, Dr. Reddy's Laboratories consistently reported higher costs, peaking in 2024 with a 115% increase from 2014. In contrast, Vertex Pharmaceuticals showed a steady growth, with costs rising by approximately 1,970% over the same period. Notably, 2023 data for Vertex is missing, indicating potential reporting delays or strategic shifts. This comparison highlights the contrasting financial strategies of these two industry leaders, with Dr. Reddy's focusing on high-volume production and Vertex on innovative drug development. As the pharmaceutical landscape continues to shift, understanding these cost dynamics is essential for investors and industry analysts alike.
Cost of Revenue Comparison: Novo Nordisk A/S vs Vertex Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Intra-Cellular Therapies, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Dyne Therapeutics, Inc.
Cost Insights: Breaking Down United Therapeutics Corporation and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue Trends: Incyte Corporation vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Alkermes plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.